China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) announced plans to transfer its entire stake of 9.4 million shares in Unicorn II Holdings Limited to Calcite Gem, a subsidiary of Warburg Pincus. The transaction, valued at USD13.2 per share, totals USD124 million. Upon completion, Fosun will no longer hold any equity in Unicorn II Holdings.
Background on Unicorn II Holdings Limited
Unicorn II Holdings Limited was founded in 2021. Through its controlling subsidiary New Frontier Health Corporation, it owns and operates United Family Healthcare (UFH), a private healthcare provider in China. New Frontier Health Corporation merged with Unicorn II Holdings Ltd and related subsidiaries in 2021.
Transaction Details
The transfer of shares represents a significant move by Fosun to divest from Unicorn II Holdings. Warburg Pincus, through its subsidiary Calcite Gem, is acquiring the shares at a price of USD13.2 each. This transaction underscores the dynamic nature of investments in China’s healthcare sector.-Fineline Info & Tech
